XERIS PHARMACEUTICALS INC

Profile

Company Names

XERIS PHARMACEUTICALS INC

Addresses

180 NORTH LASALLE STREET, STE 1800, CHICAGO, IL 60601

3208 RED RIVER STREET, STE 300, AUSTIN, TX 78705

3208 RED RIVER STREET, SUITE 300, AUSTIN, TX 78705

3925 WEST BRAKER LANE, THIRD FLOOR, AUSTIN, TX 78759

Phone Numbers

512-498-2670
888-570-4781
512-534-8340

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER TECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$86,483,865.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2017-05-17 
$30,050,443.00 
$44,999,999.00 
$14,949,556.00 
Equity 
4
2015-12-31 
$45,005,982.00 
$49,999,995.00 
$4,994,013.00 
Equity 
3
2014-09-17 
$7,274,592.00 
$14,874,990.00 
$7,600,398.00 
Equity 
2
2012-05-25 
$2,315,000.00 
$3,000,000.00 
$685,000.00 
Debt 
1
2011-07-05 
$1,837,848.00 
$1,958,748.00 
$120,900.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DOUG 
 
BAUM 
DIRECTOR
XERIS PHARMACEUTICALS INC
DOUGLAS 
 
BAUM 
EXECUTIVE OFFICER, DIRECTOR
XERIS PHARMACEUTICALS INC   |  ECHO TESTING GROUP, LLC   |  QSAM BIOSCIENCES, INC.
SHANE 
 
BRISBIN 
DIRECTOR
XERIS PHARMACEUTICALS INC
PAUL 
 
EDICK 
EXECUTIVE OFFICER, DIRECTOR
INFORMED MEDICAL COMMUNICATIONS, INC.   |  NEWLINK GENETICS CORP   |  XERIS PHARMACEUTICALS INC
ROBERT 
 
FAULKER 
DIRECTOR
XERIS PHARMACEUTICALS INC
BRAD 
 
HUCKABEE 
EXECUTIVE OFFICER
XERIS PHARMACEUTICALS INC
PHILLIP 
 
JOHNSON 
EXECUTIVE OFFICER
STANDARD ETHANOL, LLC   |  INCAPITAL HOLDINGS LLC   |  XERIS PHARMACEUTICALS INC   |  QBDVISION, INC.
JOHN 
 
KINZEL 
EXECUTIVE OFFICER, DIRECTOR
XERIS PHARMACEUTICALS INC
JOHN 
 
KINZELL 
EXECUTIVE OFFICER, DIRECTOR
XERIS PHARMACEUTICALS INC
CARY 
 
MCNAIR 
DIRECTOR
XERIS PHARMACEUTICALS INC   |  COLUBRISMX, INC.
STEVEN 
 
PRESTRELSKI 
EXECUTIVE OFFICER, DIRECTOR
XERIS PHARMACEUTICALS INC
NAVNEET 
 
PURI 
DIRECTOR
INNOPHARMA, INC.   |  XERIS PHARMACEUTICALS INC   |  NEVAKAR LLC   |  NEVAKAR INC.
JONATHAN 
 
RIGBY 
DIRECTOR
STEADYMED LTD.   |  XERIS PHARMACEUTICALS INC   |  SERNOVA CORP.   |  SERNOVA BIOTHERAPEUTICS INC.
YASH 
 
SABHARWAL 
EXECUTIVE OFFICER
XERIS PHARMACEUTICALS INC
MARK 
 
SALIMAN 
EXECUTIVE OFFICER
XERIS PHARMACEUTICALS INC
JOHN 
 
SHANNON 
EXECUTIVE OFFICER
CLOUDCOVER, LTD.   |  XERIS PHARMACEUTICALS INC
POUL 
 
STRANGE 
EXECUTIVE OFFICER
XERIS PHARMACEUTICALS INC
TIMOTHY 
 
SULLIVAN 
DIRECTOR
VARIETAL DISTRIBUTION HOLDINGS LLC   |  FIDELIS SECURITY SYSTEMS INC   |  TILANA SYSTEMS CORP   |  TRUE ULTIMATE STANDARDS EVERYWHERE, INC.   |  ANCESTRY.COM INC.   |  AGQUEST FINANCIAL SERVICES INC   |  XERIS PHARMACEUTICALS INC   |  SAGE PRODUCTS HOLDINGS, LLC   |  HOME LAB, INC   |  NPULSE TECHNOLOGIES, INC.   |  COMPOUND HOLDINGS I, LLC   |  MUSTANG INVESTMENT HOLDINGS L.P.   |  MOLECULAR TEMPLATES, INC.   |  123 CAMINO CARMELITA LLC   |  NEW ENGLAND INNOVATION CENTER, LLC   |  KH ACQUISITION, LLC   |  HC GROUP HOLDINGS I, LLC   |  MDP HC HOLDINGS, LLC   |  LANAI HOLDINGS I, LLC   |  G1 THERAPEUTICS, INC.   |  MDP ACM HOLDINGS, LLC   |  SM HOLDCO, LLC   |  ARCADIA LANDING LLC   |  CAVEONIX INC.   |  SURGICAL TRAINING SIMULATORS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-05-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-17 
2016-12-30
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-31 
2016-01-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-31 
2014-09-29
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-17 
2013-07-10
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-25 
2013-02-14
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-25 
2012-09-25
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-25 
2012-06-08
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-25 
2011-10-12
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-05 
2011-07-19
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#